1
0
0
(1 - 24 von 29
)
Overall Clinical Efficacy and Overall Tolerability of NT Wiley Online Library
onlinelibrary.wiley.com
— Poster 57: Overall Clinical Efficacy and Overall Tolerability of NT 201 (Botulinum Neurotoxin Free From Complexing Proteins). Susanne Grafe,.
A randomized, double-blind study of repeated incobotulinumtoxinA...
www.deepdyve.com
Susanne Grafe. •. Angelika Hanschmann. •. Cynthia L. Comella. Received: 9 January Accepted: 23 May Published online:
Efficacy and safety of treatment with Incobotulinum toxin A ...Acta Orthopaedica
www.medicaljournals.se
... Susanne Grafe , Irena Pulte DOI: Abstract. Objective: To investigate the efficacy and safety of repeated treatment with incobotulinum ...
efficacy and safety of treatment with incobotulinum toxin aMedical Journals Sweden
medicaljournalssweden.se
von P Kaňovský · · Zitiert von: 108 — Thomas Platz, MD, PhD4, Georg Comes5, Susanne Grafe, MD5 and Irena Pulte, MD5. From the 1Department of Neurology, Palacky University Medical School, ...
PM&R | Vol 2, Issue 9, Suppl, Pages A1-A10, S1-S206 (September 2010)...
www.sciencedirect.com
Poster 57: Overall Clinical Efficacy and Overall Tolerability of NT 201 (Botulinum Neurotoxin Free From Complexing Proteins). Susanne Grafe, Georg Comes, ...
Susanne Grafe – ScienceOpen
www.scienceopen.com
Botulinum Neurotoxin Type A Free of Complexing Proteins (XEOMIN??) in Focal Dystonia. Authors: Wolfgang H Jost, J??rg Bl??mel, Susanne Grafe.
IncobotulinumtoxinA (Xeomin®) injected for blepharospasm or cervical...
core.ac.uk
Susanne Grafe e, Angelika Hanschmann e a Movement Disorders Center of Arizona, E. Ironwood Square Drive, Suite 225, Scottsdale, ...
Botulinum toxin to introduce temporary infertility in a ...Google
patents.google.com
Application filed by Susanne Grafe, Florian Prof. Dr. med. Heinen Application granted Publication of ES T3.
DE D1 - DEVICE AND METHOD FOR THE ...Google Patents
patents.google.com
ES T Susanne Grafe Botulinum toxin to introduce temporary infertility in a vertebrate (for example, a human being). LT T ...
"A randomized, double-blind study of repeated ...University of Memphis Digital Commons
digitalcommons.memphis.edu
von VGH Evidente · · Zitiert von: 75 — Susanne Grafe, Merz GmbH & Co. KGaA · Angelika Hanschmann, Merz GmbH & Co. KGaA · Cynthia L. Comella, Rush University. Abstract. IncobotulinumtoxinA (Xeomin®, ...
Botulinum neurotoxin type A free of complexing proteins ...Gale
link.gale.com
Authors: Wolfgang H. Jost, Jorg Blumel and Susanne Grafe. Date: Mar. 15, From: Drugs(Vol. 67, Issue 5). Publisher: Wolters Kluwer Health, Inc.
Botulinum neurotoxin type A free of complexing proteins ...National Institutes of Health (.gov)
pubmed.ncbi.nlm.nih.gov
von WH Jost · · Zitiert von: 161 — Susanne Grafe. Affiliation. 1 Department of Neurology and Clinical Neurophysiology, Deutsche Klinik für Diagnostik, Wiesbaden, Germany. jost.neuro@dkd ...
Botulinum neurotoxin type A free of complexing proteins (XEOMIN[R])...
go.gale.com
includes Botulinum neurotoxin type A free of complexing proteins by Wolfgang H. Jost, Jorg Blumel, and Susanne Grafe. Click to explore.
Content - Volume 43, Issue 6Medical Journals Sweden
www.medicaljournals.se
... Susanne Grafe , Irena Pulte. Objective: To investigate the efficacy and safety of repeated treatment with incobotulinum toxin A (botulinum neurotoxin type A ...
IncobotulinumtoxinA (Xeomin®) injected for blepharospasm or ...cyberleninka.org › article
cyberleninka.org
Comella, Susanne Grafe, et al. Abstract Typically, botulinum toxin injections ... Susanne Grafe: Conception or design of the study, data acquisition, data ...
Efficacy and safety of incobotulinumtoxinA (NT 201, ...Europe PMC
europepmc.org
von J Jankovic · · Zitiert von: 100 — ... Susanne Grafe. Search articles by 'Susanne Grafe' · Grafe S. Author information. Affiliations. 1 author. 1. Department of Neurology, Baylor College of Medicine ...
Efficacy and safety of incobotulinumtoxinA (NT 201, ...Journal of the Neurological Sciences
www.jns-journal.com
Truong, Angelika Hanschmann, Susanne Grafe. Journal of the Neurological Sciences. Volume 308 Issue 1 Pages (September 2011). DOI: j.jns
Efficacy and safety of incobotulinumtoxinA (NT 201, ...Read by QxMD
read.qxmd.com
... Susanne Grafe. Journal of the Neurological Sciences September 16. OBJECTIVE: IncobotulinumtoxinA differs from available formulations in that it does not ...
Neurophysiological double-blind trial of a botulinum ...National Institutes of Health (.gov)
pubmed.ncbi.nlm.nih.gov
von K Wohlfarth · · Zitiert von: 84 — Authors. Kai Wohlfarth , Christian Müller, Irena Sassin, Georg Comes, Susanne Grafe. Affiliation. 1 Humaine Klinikum Bad Saarow, Germany. PMID: ; DOI ...
Neurophysiological double-blind trial of a botulinum ...Read by QxMD
read.qxmd.com
Kai Wohlfarth, Christian Müller, Irena Sassin, Georg Comes, Susanne Grafe. Clinical Neuropharmacology OBJECTIVE: Safety and efficacy of botulinum ...
Efficacy and safety of treatment with incobotulinum toxin A ...medicaljournalssweden.se › jrm › article › view
medicaljournalssweden.se
· Comella, Susanne Grafe, Angelika Hanschmann (2014). IncobotulinumtoxinA (Xeomin®) injected for blepharospasm or cervical dystonia according ...
Alle Infos zum Namen "Susanne Grafe"
Verwandte Suchanfragen zu Susanne Grafe
Irena Pulte Angelika Hanschmann Roman Görtelmeyer | Jorg Blumel |
Person "Grafe" (3) Vorname "Susanne" (57036) Name "Grafe" (670) |
sortiert nach Relevanz / Datum